Sichuan Kelun Pharmaceutical Co., Ltd. (002422.SZ)
CNY 30.51
(-0.46%)
CNY 30.51
(-0.46%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 13.22 Billion CNY | -23.27% |
| 2022 | 17.23 Billion CNY | -1.03% |
| 2021 | 17.41 Billion CNY | -3.17% |
| 2020 | 17.98 Billion CNY | 2.28% |
| 2019 | 17.57 Billion CNY | 7.21% |
| 2018 | 16.39 Billion CNY | 2.44% |
| 2017 | 16 Billion CNY | 34.01% |
| 2016 | 11.94 Billion CNY | 4.59% |
| 2015 | 11.41 Billion CNY | 11.6% |
| 2014 | 10.23 Billion CNY | 29.15% |
| 2013 | 7.92 Billion CNY | 35.05% |
| 2012 | 5.86 Billion CNY | 131.48% |
| 2011 | 2.53 Billion CNY | 45.8% |
| 2010 | 1.73 Billion CNY | -0.9% |
| 2009 | 1.75 Billion CNY | 19.65% |
| 2008 | 1.46 Billion CNY | 33.75% |
| 2007 | 1.09 Billion CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 11.8 Billion CNY | -10.72% |
| 2024 Q2 | 12.1 Billion CNY | 2.59% |
| 2024 Q3 | 12.16 Billion CNY | 0.42% |
| 2023 Q4 | 13.22 Billion CNY | -3.87% |
| 2023 Q1 | 17.51 Billion CNY | 1.62% |
| 2023 FY | 13.22 Billion CNY | -23.27% |
| 2023 Q2 | 16.41 Billion CNY | -6.28% |
| 2023 Q3 | 13.75 Billion CNY | -16.2% |
| 2022 FY | 17.23 Billion CNY | -1.03% |
| 2022 Q4 | 17.23 Billion CNY | -4.87% |
| 2022 Q3 | 18.11 Billion CNY | 1.35% |
| 2022 Q2 | 17.87 Billion CNY | -7.48% |
| 2022 Q1 | 19.31 Billion CNY | 10.95% |
| 2021 Q1 | 17.65 Billion CNY | -1.79% |
| 2021 Q3 | 17.75 Billion CNY | -2.18% |
| 2021 Q4 | 17.41 Billion CNY | -1.93% |
| 2021 Q2 | 18.14 Billion CNY | 2.77% |
| 2021 FY | 17.41 Billion CNY | -3.17% |
| 2020 Q2 | 17.48 Billion CNY | -6.72% |
| 2020 Q4 | 17.98 Billion CNY | -1.04% |
| 2020 FY | 17.98 Billion CNY | 2.28% |
| 2020 Q3 | 18.16 Billion CNY | 3.89% |
| 2020 Q1 | 18.74 Billion CNY | 6.66% |
| 2019 Q2 | 16.92 Billion CNY | 1.87% |
| 2019 FY | 17.57 Billion CNY | 7.21% |
| 2019 Q1 | 16.61 Billion CNY | 1.31% |
| 2019 Q4 | 17.57 Billion CNY | 7.86% |
| 2019 Q3 | 16.29 Billion CNY | -3.69% |
| 2018 Q3 | 16.23 Billion CNY | 5.15% |
| 2018 Q4 | 16.39 Billion CNY | 0.97% |
| 2018 Q1 | 16.35 Billion CNY | 2.17% |
| 2018 Q2 | 15.44 Billion CNY | -5.57% |
| 2018 FY | 16.39 Billion CNY | 2.44% |
| 2017 Q2 | 13.06 Billion CNY | -4.43% |
| 2017 FY | 16 Billion CNY | 34.01% |
| 2017 Q4 | 16 Billion CNY | 7.2% |
| 2017 Q3 | 14.93 Billion CNY | 14.28% |
| 2017 Q1 | 13.67 Billion CNY | 14.47% |
| 2016 Q3 | 12.27 Billion CNY | -1.68% |
| 2016 Q4 | 11.94 Billion CNY | -2.71% |
| 2016 Q2 | 12.48 Billion CNY | 1.62% |
| 2016 FY | 11.94 Billion CNY | 4.59% |
| 2016 Q1 | 12.28 Billion CNY | 7.61% |
| 2015 Q1 | 10.37 Billion CNY | 1.41% |
| 2015 FY | 11.41 Billion CNY | 11.6% |
| 2015 Q3 | 11.19 Billion CNY | 8.35% |
| 2015 Q4 | 11.41 Billion CNY | 2.05% |
| 2015 Q2 | 10.32 Billion CNY | -0.46% |
| 2014 Q4 | 10.23 Billion CNY | 6.33% |
| 2014 Q3 | 9.62 Billion CNY | 10.93% |
| 2014 Q2 | 8.67 Billion CNY | 7.98% |
| 2014 FY | 10.23 Billion CNY | 29.15% |
| 2014 Q1 | 8.03 Billion CNY | 1.4% |
| 2013 FY | 7.92 Billion CNY | 35.05% |
| 2013 Q4 | 7.92 Billion CNY | -5.91% |
| 2013 Q3 | 8.42 Billion CNY | 19.59% |
| 2013 Q2 | 7.04 Billion CNY | -4.49% |
| 2013 Q1 | 7.37 Billion CNY | 25.67% |
| 2012 FY | 5.86 Billion CNY | 131.48% |
| 2012 Q1 | 2.68 Billion CNY | 5.93% |
| 2012 Q2 | 5.32 Billion CNY | 98.3% |
| 2012 Q3 | 4.89 Billion CNY | -8.0% |
| 2012 Q4 | 5.86 Billion CNY | 19.78% |
| 2011 Q1 | 1.95 Billion CNY | 12.46% |
| 2011 FY | 2.53 Billion CNY | 45.8% |
| 2011 Q3 | 2.41 Billion CNY | 12.47% |
| 2011 Q4 | 2.53 Billion CNY | 5.13% |
| 2011 Q2 | 2.14 Billion CNY | 9.65% |
| 2010 Q2 | 1.54 Billion CNY | -10.46% |
| 2010 Q1 | 1.72 Billion CNY | -1.91% |
| 2010 Q3 | 1.49 Billion CNY | -2.76% |
| 2010 Q4 | 1.73 Billion CNY | 16.04% |
| 2010 FY | 1.73 Billion CNY | -0.9% |
| 2009 FY | 1.75 Billion CNY | 19.65% |
| 2009 Q4 | 1.75 Billion CNY | 0.0% |
| 2008 FY | 1.46 Billion CNY | 33.75% |
| 2007 FY | 1.09 Billion CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 9.12 Billion CNY | -44.843% |
| Zhejiang Zhenyuan Share Co., Ltd. | 974.86 Million CNY | -1256.169% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | 1.21 Billion CNY | -989.004% |
| Hubei Guangji Pharmaceutical Co., Ltd. | 1.63 Billion CNY | -707.59% |
| Yifan Pharmaceutical Co., Ltd. | 3.14 Billion CNY | -320.384% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | 84.57 Million CNY | -15531.399% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | 762.32 Million CNY | -1634.28% |
| Boai NKY Medical Holdings Ltd. | 499.66 Million CNY | -2545.956% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | 258.46 Million CNY | -5015.214% |